Stock market Investment, live NSE Nigeria, Finance Portfolio Investor/Management, Nigeria financial news

INCOME STATEMENT

GlaxoSmithkline Consumer Nigeria Plc
Statements Comprehensive Income
For the period ended 31 March 2014
	Q1 2014	Q1 2013
	N'000	N'000	%CHNG

Revenue	7,803,704	6,927,056	12.66%
Cost of sales	-4,855,087	-4,216,729	15.14%
	2,948,617	2,710,327	8.79%
Gross profit

Other Operating income	3,712	14,862	-75.02%
Selling and distribution costs	-1,373,915	-1,399,483	-1.83%
Administration expenses	-598,852	-400,885	49.38%
Other Operating expenses	-107,527	-88,930	20.91%

Operating profit	872,035	835,891	4.32%

Finance costs	-287	0
Finance income	20,385	28,941	-29.56%

Profit before tax	892,133	864,832	3.16%

Income tax expense	-276,561	-268,098	3.16%

Profit for the year	615,572	596,734	3.16%


Other comprehensive income:
Items that will not be reclassified to profit or loss:
Remeasurements on post employment benefit obligations
Income tax effect
Other copmprehensive income for the year,
net of tax


Total copmprehensive income for the year,
net of tax	615,572	596,734	3.16%

Earning per share (Kobo)

Basic and diluted,profit for the year attributable
to ordinary holders equity holders of the parent	64	62	3.23%

Source - NSE Website / Glaxosmithkline Plc